InverseOne

Celltrion Pharm: past coverage

KOSDAQ 068760

Nov. 10, 2026KoreaEarnings

Operating profit rose 48.4% from a year earlier

The preliminary third-quarter results confirm that both revenue and profit increased from the same quarter a year earlier.